SavedAdd your journal

Journals / Retina-Vitreus / 2008 / Cilt: 16 - Sayı: 2

Photodynamic therapy in choroidal neovascularization secondary to central serous chorioretinopathy

Santral seröz korioretinopatiye bağlı koroid neovaskülarizasyonunda fotodinamik tedavi

Serra Arf KARAÇORLU
Fevzi ŞENTÜRK
Hakan ÖZDEMİR
Murat KARAÇORLU
Pages
149–152
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In all eyes, stoppage of the leakage was noted as compared to the pre-PDT FFA.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Four eyes of four patients with choroidal neovasculariza- tion (CNV) secondary to central serous chorioretinopathy (CSCR) documented by fundus fluorescein angiography (FFA) received photodynamic therapy (PDT) according to the parameters outlined in the ‘Treatment of Age-Related Macular Degeneration with Photodynamic Therapy’ (TAP) study.
📊
Key Findings & Data:Visual acuity improved 2 to 6 lines in three eyes and did not change in one eye.
💡
Conclusion & Impact:In all eyes, stoppage of the leakage was noted as compared to the pre-PDT FFA.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Fotokemoterapi · Yaşlı · Floresan anjiyografi

Abstract

Four eyes of four patients with choroidal neovasculariza- tion (CNV) secondary to central serous chorioretinopathy (CSCR) documented by fundus fluorescein angiography (FFA) received photodynamic therapy (PDT) according to the parameters outlined in the ‘Treatment of Age-Related Macular Degeneration with Photodynamic Therapy’ (TAP) study. Patients were observed for six months to three years. Three PDT sessions were performed on one eye. All other eyes received only one PDT. Examinations included visual acuity measurement (ETDRS), fundus biomicroscopy and FFA. Visual acuity improved 2 to 6 lines in three eyes and did not change in one eye. In all eyes, stoppage of the leakage was noted as compared to the pre-PDT FFA.

Özet

Fundus flöresein anjiografi (FFA) ile tespit edilen santral seröz korioretinopatiye (SSKR) bağlı olarak gelişen koro- id neovaskülarizasyonu (KNV) bulunan dört hastanın, dört gözüne ‘Treatment of Age-Related Macular Degeneration with Photodynamic Therapy’ (TAP) çalışması tarafından be- lirlenen kriterlere uygun olarak fotodinamik tedavi (FDT) uygulandı. Hastalar altı ay ile üç yıl arası değişen süre- lerde takip edildiler. Bir göze 3 seans FDT uygulandı. Di- ğer gözlere ise tek seans FDT uygulaması yapıldı. Kontrol muayenelerinde ETDRS eşeli ile görme keskinliği ölçüldü, fundus biyomikroskopik değerlendirmesi yapıldı ve FFA çekildi. Tedavi sonrası görme keskinliği üç gözde 2 ile 6 sıra arasında artarken, bir gözde aynı seviyede kaldı. FDT öncesi çekilen FFA’lere göre kıyaslandığında sızıntının tüm gözlerde kesildiği tespit edildi.

🔖

Cite This Article

KARAÇORLU, S. A., ŞENTÜRK, F., ÖZDEMİR, H., KARAÇORLU, M. (2008). Photodynamic therapy in choroidal neovascularization secondary to central serous chorioretinopathy. Retina-Vitreus, Cilt: 16 - Sayı: 2, 149–152. https://ajindex.com/articles/305221

References (11)

  1. Gass JDM.: Pathogenesis of disciform detachment of the neuro- epithelium. II. Idiopathic central serous choroidopathy. Am J Ophthalmol. 1967;63:587-615
  2. Güven D, Aksünger A, Or M, ve ark.: Santral seröz korioretinopa- tide fundus floresein anjiografik görünümler. Ret-Vit. 1994;2:159- 165
  3. Yannuzzi LA, Shakin JL, Fisher YL, et al.: Peripheral retinal de- tachments and retinal pigment epithelial atrophic tracts secon- dary to central serous pigment epitheliopathy. Ophthalmology. 1984;91:1554-1572
  4. Treatment of Age-Related Macular Degeneration with Photody- namic Therapy (TAP) Study Group: Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: One-year results of 2 randomized clinical trials- TAP report 1. Arch Ophthalmol. 1999;117:1329- 1345
  5. Spaide RF, Campeas L, Haas A, et al.: Central serous cho- rioretinopathy in younger and older adults. Ophthalmology. 1996;103:2070-2080
  6. Güngör Ö, Şengün A, Gül G, ve ark.: Santral seröz korioretino- patide koroidal neovaskülarizasyon. Ret-Vit. 2004;12:54-57
  7. Loo RH, Scott IU, Flynn HW Jr, et al.: Factors assosiated with re- duced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy. Retina. 2002;22:19- 24
  8. Cooper BA, Thomas MA.: Submacular surgery to remove choro- idal neovascularization associated with central serous chorioreti- nopathy. Am J Ophthalmol. 2000;130:187-191
  9. Macular Photocoagulation Study Group: Argon laser photocoa- gulation for idiopathic neovascularization: Results of a randomi- zed clinical trial. Arch Ophthalmol. 1983;101:1358-1361
  10. Chan WM, Lam DS, Lai TY, et al.: Treatment of choroidal neovas- cularization in central serous chorioretinopathy by photodynamic therapy with verteporfin. Am J Ophthalmol. 2003;136:836-845
  11. Ergun E, Tittl M, Stur M.: Photodynamic therapy with verteporfin in subfoveal choroidal neovascularization secondary to central serous chorioretinopathy. Arch Ophthalmol. 2004;122:37-41.